AQP1 gene expression is upregulated by arginine vasopressin and cyclic AMP agonists in trophoblast cells.

Perinatal Research Laboratories, Department of Obstetrics and Gynecology, David-Geffen School of Medicine, University of California, Los Angeles, CA 90502, USA.
Life Sciences (Impact Factor: 2.3). 07/2008; 82(25-26):1272-80. DOI: 10.1016/j.lfs.2008.04.014
Source: PubMed

ABSTRACT Aquaporins (AQPs) are water channels that regulate water flow in many tissues. As AQP1 is a candidate to regulate placental fluid exchange, we sought to investigate the effect of arginine vasopressin (AVP) and cAMP agonists on AQP1 gene expression in first trimester-derived extravillous cytotrophoblasts (HTR-8/Svneo) and two highly proliferative carcinoma trophoblast-like cell lines but with a number of functional features of the syncytiotrophoblast namely; JAR and JEG-3 cells. Our data demonstrated that AVP (0.1 nM) significantly increased the expression of AQP1 mRNA at 10 h in HTR-8/SVneo and JEG-3 cells (P<0.05). Both SP-cAMP, a membrane-permeable and phosphodiesterase resistant cAMP, and forskolin, an adenylate cyclase stimulator significantly increased AQP1 mRNA expression in all cell lines after 2 h in a dose-dependent manner (P<0.05) with a parallel increase in protein expression. In the time course study, 5 microM of either SP-cAMP or forskolin significantly stimulated AQP1 mRNA expression after 2 h in HTR-8/SVneo cells and after 10 h in JAR and JEG-3 cells. AQP1 protein expression was highest after 20 h in both HTR-8/SVneo and JEG-3 cells (P<0.05). AVP-stimulated cAMP elevation was blocked in the presence of 9-(tetrahydro-2'-furyl) adenine (SQ22536) (100 microM), a cell-permeable adenylate cyclase inhibitor (P<0.05). These results indicate that in trophoblasts-like cells AQP1 gene expression is upregulated by both AVP and cAMP agonists. Furthermore, our data demonstrate that a cAMP-dependent pathway is responsible for the AVP effect on AQP1. Thus, modulation of AQP1 expression by maternal hormones may regulate invasion and fetal-placental-amnion water homeostasis during gestation.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The aquaporins (AQP) are a family of homologous water transporting proteins that are expressed in many epithelial, endothelial and other tissues. Myocardin is important for SMC differentiation, but its precise role in regulating the initiation of AQP1 transcription activity is less clear. Function analysis of AQP1 promoter luciferase reporter plasmid will provide the theory basis for researching the function of transcription activity. In this study, the rat and human myocardin promoter luciferase reporter construct were successfully constructed. Then to determine whether AQP1 transcription activity were regulated by myocardin, luciferase repoeter assays were performed in COS-7 cells. The results illustrated that myocardin significantly activated rat and human AQP1 promoter. AQP1 promoter transactivity was inhibited by △Q. The present study provided the first evidence that myocardin may have an influence on the expression of AQP1 and reveal a basis of the mechanism transcriptional regulation of AQP1.
    Advanced Materials Research. 11/2011; 396-398:1486-1489.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The pressure inside large arteries is typically ~100 mmHg higher than outside of them. This difference, ¿P, drives a flow of plasma, mainly water and advected/swept-along solutes, that would otherwise only transport by (much slower) diffusion [1], across the porous vessel wall. It is natural to ask whether this flow enters the wall across the endothelium solely through inter-endothelial cell (EC) junctions or whether a portion of the water traverses the ECs via membrane proteins from the ubiquitous aquaporin (AQP) family [2]. Belkacemi et al. [3] showed a 5 fold protein expressional change of AQP1 in trophoblast cells after treatment with arginine vasopressin (AVP). We have found conditions under which AVP upregulates the hydraulic conductivity (Lp) of cultured bovine aortic ECs and upregulates their AQP1 expression in vitro. Our next step is to apply this procedure to whole rat aortas ex vivo. Specific Aim 1: Study the differences in water filtration properties of BAEC mono-layers under effects of AVP treatment to upregulate AQP1 expression. (A) Measure and compare the Lp of both treated and untreated monolayers (B) Quantify protein expression change induced by AVP treatment using immunohis-tochemistry, Western Blot and/or with Quantitative Real Time Polymerase Chain Reaction (Q-RT-PCR) (for mRNA analysis). (C) Perform solute drag experiment to investigate paracellular transport in treated vs. control BAEC monolayers.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Aquaporin 1 (AQP1) and 5 (AQP5) expression may impact on key mechanisms in sepsis. However, it is unclear whether these aquaporins are expressed to an equal extent or regulated differentially. Accordingly, we investigated the time-dependent expression of AQP 1 and 5 following stimulation with LPS in cultured human THP-1 cells and in the lungs of mice injected with LPS. Furthermore, we tested the hypothesis that the ß-2 adrenoreceptor agonist terbutaline or its downstream effector cAMP mitigates LPS evoked changes of AQP expression.THP-1 cells were stimulated with either LPS (1 μg/ml; serotype O127:B8), 8-Br-cAMP (1mM), or both and RNA and protein were extracted at baseline and after 2, 6, and 24 hours. C57BL/6 mice received LPS (20 mg/kg i.p.), terbutaline (2.5 mg/kg), or both, were killed 8 h later, and lungs were excised for RNA extraction and lung wet weight determination.Real-Time-PCR and Western blot analysis show that LPS increased AQP1 (3 h, p < 0.0001) but not AQP5 mRNA and protein expression in THP-1 cells. cAMP increased AQP1 (6 h, p < 0.0001) but not AQP5 mRNA and protein expression. Incubation with both substances accelerated the increase of AQP1 (2 h, p = 0.001) expression, whereas AQP5 expression decreased after 2h but increased after 24 h (p = 0.0148).In mice lungs LPS decreased AQP1 (p = 0.0082) but not AQP5 mRNA expression and increased lung wet weight. Terbutaline increased AQP1 mRNA expression twice (p = 0.0005) but not AQP5 mRNA expression. Terbutaline did neither abolish the LPS induced decrease of AQP 1 and 5 expression nor increased lung weight.Thus, AQP 1 and 5 expression is differentially regulated following exposure to LPS, the ß-2 adrenoreceptor agonist terbutaline, and cAMP. Furthermore, neither terbutaline nor cAMP mitigated the LPS evoked change of AQP 1 and 5 expression.
    Shock (Augusta, Ga.) 10/2013; · 2.87 Impact Factor

Louiza Belkacemi